Fortrea Holdings Inc.
NASDAQ:FTREBiotechnology
-$0.07 today
- Market cap
- $1.94B
- Beta
- 2.11
- P/E (TTM)
- -3.1
- EPS (TTM)
- -$4.90
Volume 1.59M
Average 1.31M
FTRE Financing Cash Flow
Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.
Fortrea Holdings Inc.NASDAQ: FTRE
Financing Cash Flow · Q2 FY2026 · quarter ended Jun 2026
Financing cash flow turns positive
Q2 FY2026 financing cash flow was $0, compared with -$39M a year earlier. Trailing-twelve-month financing cash flow was -$125.7M. Over 3 fiscal years it compounded at +129.6% a year.
Context
- Financing cash flow amounted to 2.8% of revenue in FY2025, down 15.7 pp from a year earlier.
- Financing cash flow grew in size in 2 of the last 3 fiscal years.
What to watch
Whether quarterly financing cash flow holds near $0 or moves back toward the trailing-twelve-month quarterly average of -$31.43M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Financing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (76.3M) USD
- Year-over-year change
- +84.7%
| Period | Period end | Financing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (76.3M) | +84.7% |
| FY2024 | 2024-12-31 | (497.8M) | -253.6% |
| FY2023 | 2023-12-31 | (140.8M) | -2134.9% |
| FY2022 | 2022-12-31 | (6.3M) | +95.1% |
| FY2021 | 2021-12-31 | (128.5M) | — |
Financing Cash Flow vs competitors
How FTRE compares with its peers on the latest reported figures
- FTRE's LTM Jun 2026 financing cash flow of $125.7M is the 2nd largest of the 3 companies compared; the peer median is $170.09M.
- Its year-over-year change of -466.5% is the lowest of 3, against a peer median of +101.8%.
- Financing cash flow amounts to 4.7% of revenue for FTRE, versus a peer median of 15.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $246.45M | -76.6% | +3.5% | 8.7% | |
FTREFortrea Holdings Inc. | LTM Jun 2026 | $125.7M | -466.5% | +129.6% | 4.7% |
| LTM Mar 2026 | $93.73M | +280.1% | +105.6% | 22.3% | |
| Peer median (excluding FTRE) | $170.09M | +101.8% | +54.6% | 15.5% | |
Competitors are the stored peer set for FTRE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 98M | 186.2M | (25.2M) | (271.5M) | (986.2M) |
| Depreciation & Amortization | 166.3M | 93.6M | 98M | 86.9M | 78M |
| Deferred Income Tax | (30.2M) | (16.5M) | (41.6M) | (24.6M) | (32M) |
| Stock-Based Compensation | 27.5M | 25.4M | 42.7M | 58.4M | 74.4M |
| Change in Working Capital | (127.2M) | (248.2M) | 26.9M | 364.5M | 114.7M |
| Accounts Receivables | (187.6M) | (108.4M) | (53.4M) | 309.9M | 70.9M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | (6.2M) | 24.8M | 55.3M | 7.2M | (109.9M) |
| Other Working Capital | 66.6M | (164.6M) | 25M | 47.4M | 153.7M |
| Other Non-Cash Items | 35.4M | 42.2M | 67.6M | 49.1M | 864.6M |
| Operating Cash Flow | 169.8M | 82.7M | 168.4M | 262.8M | 113.5M |
| Capital Expenditures | (26.5M) | (54.4M) | (40.3M) | (25.5M) | (25.2M) |
| Acquisitions (Net) | 0 | 0 | 0 | 276.6M | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 300K | 400K | 8.5M | 500K | 39.6M |
| Investing Cash Flow | (26.2M) | (54M) | (31.8M) | 251.6M | 14.4M |
| Debt Repayment | 0 | 0 | 1.62B | (482.7M) | (76.3M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (128.5M) | (6.3M) | (1.76B) | (15.1M) | 0 |
| Financing Cash Flow | (128.5M) | (6.3M) | (140.8M) | (497.8M) | (76.3M) |
| Effect of Forex Changes | (800K) | (6.6M) | 2.4M | (6.7M) | 4.5M |
| Net Change in Cash | 14.3M | 15.8M | (1.8M) | 9.9M | 56.1M |
| Free Cash Flow | 143.3M | 28.3M | 128.1M | 237.3M | 88.3M |
Fortrea Holdings Inc.
NASDAQ:FTRE
Intrinsic Alpha fair value
Locked
Current Price
$20.50
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.